Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient

US11554242B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11554242-B2
Application numberUS-201916502828-A
CountryUS
Kind codeB2
Filing dateJul 3, 2019
Priority dateJun 20, 2014
Publication dateJan 17, 2023
Grant dateJan 17, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO 2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO 2 -to-NO reactor cartridge and/or a breakthrough of NO 2 , and providing an indication of the remaining useful life and/or breakthrough.

First claim

Opening claim text (preview).

What is claimed is: 1. A reactor cartridge for converting NO 2 to NO for delivery to a patient using a gas delivery system, comprising: an outer reactor shell; an inlet end wall that seals the inlet end of the reactor; an outlet end wall that seals the outlet end of the reactor to form an internal volume within the reactor cartridge; an inlet that facilitates connection of the reactor cartridge to a first gas conduit and allows passage of gas through the inlet end wall to the internal volume; an outlet that facilitates connection of the reactor cartridge to a second gas conduit and allows passage of gas through the outlet end wall to exit the reactor cartridge; a consumable conversion media retained within the internal volume of the reactor cartridge that facilitates conversion of an incoming NO 2 gas delivered to the inlet to an outgoing NO gas exiting at the outlet for delivery to the patient; a back end retainer positioned towards the outlet of the reactor cartridge to prevent consumable conversion media from exiting the internal volume of the reactor cartridge through the outlet; a front end retainer positioned towards the inlet of the reactor cartridge to prevent consumable conversion media from exiting the internal volume of the reactor cartridge through the inlet, wherein the consumable conversion media is retained between the front end retainer and the back end retainer; a force-applying member positioned between the inlet end wall and the front end retainer to apply a pressure to the consumable conversion media; and a memory chip affixed to the outer reactor shell, wherein the memory chip stores data relating to the conversion cartridge that the chip is affixed to on a non-transient computer readable medium, wherein the stored data comprises identification data, testing data, and cartridge life data, wherein the memory chip is configured to be in electronic communication with a computer and wherein the computer is configured to read the stored data and prevent the gas delivery system from entering an operational state if the identification data, testing data, or cartridge life data exceeds a stored average expected identification data, testing data, or cartridge life data, wherein the identification data includes a cartridge serial number, a lot and/or batch number, a production date, and/or an expiration date, the testing data includes a weight of consumable conversion media within the conversion cartridge, values of test results showing conversion efficiency of NO 2 to NO, pressure drop across the consumable conversion media, and/or a humidity level of the consumable conversion media, and the cartridge life data includes average expected cartridge life calculated from the testing data, total expected NO 2 conversion by weight, concentration, and/or volume, and/or expected duration of usage at an average gas flow rate. 2. The reactor cartridge of claim 1 , which further comprises an impact sensor affixed to and/or operatively associated with the reactor cartridge, wherein the impact sensor is configured to determine the number of impacts and/or the severity of the impact(s) experienced by the reactor cartridge. 3. The reactor cartridge of claim 1 , which further comprises an inlet with a keyed or polarized cartridge connector and/or an outlet with a keyed or polarized cartridge connector, wherein the keyed or polarized inlet and/or outlet connectors interact with a mechanical interlock to ensure the reactor cartridge is installed with the correct orientation in a gas delivery system.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11554242B2 cover?
The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO 2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide…
Who is the assignee on this patent?
Mallinckrodt Pharmaceuticals Ireland Ltd
What technology area does this patent fall under?
Primary CPC classification A61M16/122. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).